Under Access, we share best practice guidance on how to expand access to safe abortion and post-abortion care.

view all


An estimated 25 million unsafe abortions occur every year. Under Awareness, we share strategies for increasing awareness of safe services.

view all


Under Quality, we share resources for delivering high-quality clinical care in safe abortion and post-abortion care programming.

view all


Under Policy, we share guidance and resources for overcoming common barriers to safe services and care.

view all
sign up for updates

23 Jul 2020

Guidance for providers offering medical abortion with misoprostol during COVID-19

Gynuity Health Projects


Pathways to care, Pharmacy provision, Medical Abortion (MA), Commodities, Product Quality, Self-administration

With COVID-19 shifting access to safe abortion services, Gynuity Health Projects and CEDES, in collaboration with ASAP, CLACAI, REDAAS and Women Help Women, have developed a resource to support providers to administer misoprostol for a medical abortion safely during the COVID-19 pandemic, and in accordance with social distancing recommendations.

The guidance reviews the steps of providing misoprostol medical abortion and makes evidence-based recommendations for limiting contact and reducing in-person visits.

The resource is currently available on CEDES’ and Gynuity’s websites in English, Spanish, French, Portuguese and Russian in both PDF and mobile format.

Visit Gynuity’s website to download the guides.

Close comments

view comments

Sign up

Subscribe to our newsletter to receive the latest SafeAccess articles, straight to your inbox.

sign up

By clicking 'subscribe' you are accepting the terms and conditions of our privacy policy, and consent to receive email updates from SafeAccess. We will not sell your data, and promise to keep your information safe.


Success! You have successfully subscribed to the list.